Search
The US Food and Drug Administration announced today that the drug ipilimumab (brand name Yervoy) has been approved for the treatment of patients with metastatic melanoma. It is the first drug ever shown to improve overall survival for patients with advanced melanoma.
MSK researchers are leading the development of new artificial intelligence (AI) models to improve the targeting of radiation therapy — teaching computers to better isolate tumors and spare more of the surrounding healthy tissue.
During the pandemic, Dr. John Chodera’s lab shifted gears to help find new drugs against COVID-19. Learn how lessons from the effort are already aiding in the search for new cancer drugs.
What do you get when you combine two of the hottest areas of biotechnology? A new paper from MSK researchers explains.
In 2024, patients from more than 70 countries — from Gambia and Japan to Italy and Brazil — came to MSK seeking our medical expertise and compassionate care.
To recognize the beginning of Lung Cancer Awareness Month, MSK shared four important pieces of information for individuals at high risk of lung cancer and their loved ones.
Researchers from MSK and Weill Cornell have found that two compounds appear to fight off infection with the Zika virus.
Official rare cancer fundraising program of Memorial Sloan Kettering Cancer Center to host its stationary-cycling events in 16 locations nationwide. Instructors from Equinox, Cycle for Survival’s founding partner, will lead the high-energy rides.
MSK Kids staff made some clever tweaks and a few adjustments to host the ultimate “mask-erade” prom.